Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serge Braun

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Medecine Sciences : M/S|February 27, 2024
[Gene therapy: A transformative, multifaceted family of drugs at a crossroads]Serge Braun
Current Opinion in Molecular Therapeutics|November 13, 2004
Naked plasmid DNA for the treatment of muscular dystrophySerge Braun
Medecine Sciences : M/S|April 4, 2019
[Biotherapies: a revolution on the move]Serge Braun
Current Gene Therapy|October 16, 2008
Muscular gene transfer using nonviral vectorsSerge Braun
Medecine Sciences : M/S|March 5, 2020
[Gene-based therapies of spinal muscular atrophy: a piece of history of medicine]Serge Braun
The Journal of Gene Medicine|October 15, 2013
Gene-based therapies of neuromuscular disorders: an update and the pivotal role of patient organizations in their discovery and implementationSerge Braun
Presse Medicale (Paris, France : 1983)|April 3, 2012
[Rare diseases: Innovation laboratories for human health]Serge Braun
Medecine Sciences : M/S|December 21, 2019
[Cell therapy in muscular disorders: the future lies in comparisons of progenitors]Jean-Thomas Vilquin, Serge Braun
The Science of the Total Environment|October 8, 2016
Artificial macropores attract crop roots and enhance plant productivity on compacted soilsTino Colombi, Serge Braun, Thomas Keller, et al.
Neuromuscular Disorders : NMD|September 11, 2002
Current protocol of a research phase I clinical trial of full-length dystrophin plasmid DNA in Duchenne/Becker muscular dystrophies. Part I: rationaleChristine Thioudellet, Stéphane Blot, Patrick Squiban, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Medecine Sciences : M/S|February 27, 2024
[Gene therapy: A transformative, multifaceted family of drugs at a crossroads]Serge Braun
Current Opinion in Molecular Therapeutics|November 13, 2004
Naked plasmid DNA for the treatment of muscular dystrophySerge Braun
Medecine Sciences : M/S|April 4, 2019
[Biotherapies: a revolution on the move]Serge Braun
Current Gene Therapy|October 16, 2008
Muscular gene transfer using nonviral vectorsSerge Braun
Medecine Sciences : M/S|March 5, 2020
[Gene-based therapies of spinal muscular atrophy: a piece of history of medicine]Serge Braun
The Journal of Gene Medicine|October 15, 2013
Gene-based therapies of neuromuscular disorders: an update and the pivotal role of patient organizations in their discovery and implementationSerge Braun
Presse Medicale (Paris, France : 1983)|April 3, 2012
[Rare diseases: Innovation laboratories for human health]Serge Braun
Medecine Sciences : M/S|December 21, 2019
[Cell therapy in muscular disorders: the future lies in comparisons of progenitors]Jean-Thomas Vilquin, Serge Braun
The Science of the Total Environment|October 8, 2016
Artificial macropores attract crop roots and enhance plant productivity on compacted soilsTino Colombi, Serge Braun, Thomas Keller, et al.
Neuromuscular Disorders : NMD|September 11, 2002
Current protocol of a research phase I clinical trial of full-length dystrophin plasmid DNA in Duchenne/Becker muscular dystrophies. Part I: rationaleChristine Thioudellet, Stéphane Blot, Patrick Squiban, et al.
Pageof 3